1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEKTAR THERAPEUTICS
Nektar Therapeutics XNAS: NKTR

Nektar Therapeutics Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the fiel...

Read More
73.33 1.26 (1.75%)
Near 52W High of $75.67
578.5K
XNAS Volume

XNAS 11 Mar, 2026 4:11 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Nektar Therapeutics is on 13 Mar 2026 for the purpose of Nektar Therapeutics Annual Report for 2025 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
5.5 / 100
Momentum Score
Technically Moderately Bullish
68.9 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
130
1Yr Price target upside is 77%
7 analysts

25

S

6

W

1

O

3

T

SWOT Analysis

Nektar Therapeutics Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..